)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Shanghai Fosun Pharmaceutical
Shanghai Fosun Pharmaceutical (600196) investor relations material
Shanghai Fosun Pharmaceutical Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary28 Apr, 2026
Executive summary
Revenue for Q1 2026 reached RMB 10.07 billion, up 6.93% year-over-year; net profit attributable to shareholders rose 13.87% to RMB 870.83 million.
Four innovative drug applications were accepted and 14 clinical trial applications were approved by domestic and international regulators.
Notable pipeline progress includes approvals and clinical advancements for drugs targeting oncology and rare diseases.
Financial highlights
Operating income for Q1 2026 was RMB 1.36 billion, up 0.74% year-over-year.
Net profit attributable to shareholders excluding non-recurring items increased 21.96% year-over-year to RMB 500.53 million.
Basic and diluted EPS both rose 13.79% to RMB 0.33.
Operating cash flow increased 8.8% year-over-year to RMB 1.15 billion.
Total assets at quarter-end were RMB 122.97 billion, up 2.43% from year-end 2025.
Outlook and guidance
Continued focus on innovation and internationalization, with new drug applications and clinical trials expected to drive future growth.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Shanghai Fosun Pharmaceutical
- Net profit surged 21.69% to RMB 3.37 billion on steady revenue and strong innovation drug growth.600196
H2 202524 Mar 2026 - Net profit rose 38.96% to RMB 1,702 million despite a 4.63% revenue drop, led by asset sales and innovation.600196H1 202523 Jan 2026
- Net profit rose 16.08% year-over-year as innovation and global expansion offset revenue softness.600196H2 202411 Dec 2025
- Net profit rose 25.42% year-over-year despite a 7.26% revenue decline from VBP and asset sales.600196Q1 202511 Dec 2025
- Net profit rose 25.5% year-over-year despite revenue decline, led by asset sales and innovation.600196Q3 202521 Nov 2025
- Q3 net profit jumped 55.4% YoY, led by innovation and healthcare services growth.600196Q3 202413 Jun 2025
- Revenue and profit fell, but innovative drug and overseas growth offset COVID declines.600196H1 202413 Jun 2025
Next Shanghai Fosun Pharmaceutical earnings date
Q2 202626 Aug, 2026
Shanghai Fosun Pharmaceutical
Next Shanghai Fosun Pharmaceutical earnings date
Q2 202626 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage